Abstract
Theoretischer Hintergrund: Die Krankheitsbewältigung spielt eine wichtige Rolle für die psychische Gesundheit und das Wohlbefinden von Patienten mit amyotropher Lateralsklerose (ALS). Fragestellung: Die vorliegende Studie untersuchte Angst, Depression und individuelle Lebensqualität sowie assoziierte Faktoren bei ALS. Methode: Die Stichprobe umfasste 39 ALS-Patienten (20 Frauen, Durchschnittsalter 58 Jahre, Durchschnitts-Erkrankungsdauer 2.4 Jahre). Eingesetzt wurden die Sektionen A, D, F und teilweise J des SKID-I, das ALS-Depressionsinventar (ADI-12), der Schedule for the Evaluation of Individual Quality of Life–Direct Weigthening (SEIQoL-DW) und die Liste zur Erfassung von Verstärkern (LEV). Ergebnisse: Auftretenshäufigkeiten für eine Major Depression Episode: 10 %, für depressive Störungen insgesamt: 23 %, für Angststörungen: 21 %. Die Erstmanifestation einer Major Depression lag bei 4 von 9 Patienten vor der ALS-Diagnose. Nur die Hälfte der Patienten mit der Depressions-Lebenszeitdiagnose erlebte nach der ALS-Diagnose eine weitere Episode. Depressionen waren assoziiert mit weiblichem Geschlecht, einem geringeren Bildungsniveau, geringerer Lebensqualität und einer geringeren Anzahl positiv verstärkender Aktivitäten. Die individuelle Lebensqualität (iLQ) lag bei 72 von 100. Depressive Patienten zeigten dabei eine stärkere Orientierung auf die Gesundheit als nicht depressive Patienten. Schlussfolgerung: Trotz hoher individueller Lebensqualität traten Depressionen und Angststörungen gehäuft auf. Psychotherapeutische Unterstützung ist angezeigt, vor allem im Sinne einer Einstellungs- und Werteveränderung, beim Aufbau oder Erhalt von Verstärkern sowie als kognitive Therapie bei erlebtem Kontrollverlust.
Background. Patients with amyotrophic lateral sclerosis (ALS) are challenged to cope with a progressive and fatal disease and how to maintain mental health and individual quality of life. Objectives: The purpose of this study was to examine depression, anxiety, and individual quality of life as well as associated factors in ALS patients. Methods: A sample of 39 ALS patients (20 women, average age 58 years, average disease duration 2.4 years) completed the following questionnaires/interviews: SCID-I Section A, D, F, and partially J; ALS depression inventory (ADI-12); Schedule for the Evaluation of Individual Quality of Life–Direct Weighting (SEIQoL-DW); Schedule of Reinforcement (LEV). Results: Prevalence for a major depression episode was 10 %, prevalence of any depression disorder was 23 %, prevalence for anxiety disorders was 21 %. In 4 of 9 patients onset of the major depression episode was prior to ALS diagnosis. Only 50 % of patients with a major depression lifetime diagnosis experienced another major depression episode after being diagnosed with ALS. There was an association between more symptoms of depression and female gender, lower level of education, poorer quality of life, and lower number of reinforcing activities. With an average score of 72 (of 100) individual quality of life was high. Depressed ALS patients stated health as a more important factor for individual quality of life than did non-depressed patients. Conclusions: Despite high individual quality of life the prevalence of depression and anxiety disorders was increased. Psychological support or psychotherapy is required, most notably to change attitudes and intrinsic values, to extend or sustain reinforcing activities, and for cognitive restructuring when experiencing loss of control.
Literatur
1996). The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology, 53 (2), 141 – 147.
(2011). Depression in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12 (4), 109 – 112.
(2004). Psychische Störungen bei Patienten mit muskuloskelettalen und kardiovaskulären Erkrankungen im Vergleich zur Allgemeinbevölkerung. Zeitschrift für Klinische Psychologie und Psychotherapie, 33 (1), 33 – 41.
(2002). Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology, 58 (2), 320 – 322.
(2005). Psychopathology in amyotrophic lateral sclerosis: A preliminary study with 27 ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 6 (4), 221 – 225.
(2005). Individual quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolsin (reovirus). Health and Quality of Life Outcomes, 3, 7.
(2001). Assessing individual quality of life in amyotrophic lateral sclerosis. Quality of Life Research, 10 (2), 149 – 158.
(2005). Personal values and individual quality of life in palliative care patients. Journal of Pain and Symptom Management, 30 (2), 154 – 159.
(2011). Prevalence of major depression in ALS: Comparison of a semi-structured interview and four self-report measures. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 12 (4), 297 – 302.
(1999). Correlates of suffering in amyotrophic lateral sclerosis. Neurology, 52 (7), 1434 – 1440.
(2007). Withdrawn: Antidepressants for depression in medical illness. The Cochrane Database of Systematic Reviews, 18 (4), CD001312. DOI: 10.1002/14651858.CD001312.pub2
(2011). Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurology, 11, 70.
(2008). Validity of the ALS-Depression-Inventory (ADI-12)–A new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. Journal of Affective Disorders, 109 (1 – 2), 213 – 219.
(1995). BDI Beck-Depressions-Inventar (BDI). Testhandbuch (2. überarb. Aufl.). Bern: Huber.
(1998). Zur Wirksamkeit von Psychotherapien bei Depressionen. Psychotherapie 3, 65 – 75.
(1996). A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. BMJ, 313 (7048), 29 – 33.
(2009). Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Research Review, 9 (2), 131 – 141.
(2004). Psychische Störungen in der deutschen Allgemeinbevölkerung: Inanspruchnahme von Gesundheitsleistungen und Ausfalltage. Bundesgesundheitsblatt–Gesundheitsforschung–Gesundheitsschutz, 47, 736 – 744.
(2008). Brain-computer interfaces and communication in paralysis: Extinction of goal directed thinking in completely paralysed patients? Clinical Neurophysiology, 119 (11), 2658 – 2666.
(2005). Das ALS-Depressionsinventar (ADI): Ein Fragebogen zur Messung von Depression bei degenerativen neurologischen Erkrankungen (amyotrophe Lateralsklerose). Zeitschrift für Klinische Psychologie und Psychotherapie, 34 (1), 19 – 26.
(2007). Depression and anxiety in individuals with amyotrophic lateral sclerosis: Epidemiology and management. CNS Drugs, 21 (4), 279 – 291.
(2011). Pathways from education to depression. Journal of cross-cultural gerontology, 26 (2), 121 – 135.
(1974). A behavioral approach to depression. In R. J. Friedman & M. M. Katz (Eds.), The psychology of depression: Contemporary theory and research. Washington, DC: Winston-Wiley.
(2005). The SEIQoL and functional status: How do they relate? Scandinavian Journal of Caring Sciences, 19 (4), 403 – 409.
(2009). Life can be worth living in locked-in syndrome. Progress in Brain Research, 177, 339 – 351.
(1968). Anxiety. In D. L. Sills (Ed.), International encyclopedia of the social sciences. New York, NY: Crowell‐Collier.
(2010). Coping with amyotrophic lateral sclerosis: an integrative view. [Research Support, Non-U.S. Govt]. Journal of neurology, neurosurgery, and psychiatry, 81 (8), 893 – 898.
(2008). Betreuungsstrategien für schwerstgelähmte Patienten: empirische Ethik und neurowissenschaftliche Ansätze. Dissertation, Eberhard-Karls-Universität Tübingen. Retrieved March 23, 2012, from nbn-resolving.de/urn:nbn:de:bsz:21-opus-44503
(1991). Assessing the quality of life of the individual: The SEIQoL with a healthy and a gastroenterology unit population. Psychological Medicine, 21 (3), 749 – 759.
(2005). Can the concepts of depression and quality of life be integrated using a time perspective? Health Qual Life Outcomes, 3, 1.
(2000). Measuring Response Shift Using the Schedule for Evaluation of the Individual Quality of Life. In C. E. Schwartz & M. A. G. Sprangers (Eds.), Adaptation to Changing Health. Response shift in quality-of-life research. Washington, DC: American Psychological Association.
(1997). Quality of life issues in palliative medicine. Journal of Neurology, 244 (4),18 – 25.
(1993). The schedule for the evaluation of individual quality of life. User manual. Dublin: Department of Psychology, Royal College of Surgeons in Ireland.
(2010). Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time. [Research Support, Non-U.S. Govt]. Acta neurologica Scandinavica, 121 (4), 244 – 250.
(2011). Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin. Palliat Support Care, 8 (1), 75 – 82.
(2011). Existential well-being and spirituality of individuals with amyotrophic lateral sclerosis is related to psychological well-being of their caregivers. Amyotrophic Lateral Sclerosis, 12 (2), 105 – 108.
(2010). Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurologica Belgica, 110 (1), 71 – 77.
(2005). Prevalence of depressive disorders and change over time in late-stage ALS. Neurology, 65 (1), 62 – 67.
(2000). Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosomatic Medicine, 62 (2), 271 – 279.
(2001). Quality of life in ALS is maintained as physical function declines. Neurology, 56 (4), 442 – 444.
(2003). Diagnostisches und Statistisches Manual Psychischer Störungen–Textrevision–DSM-IV-TR, deutsche Bearbeitung und Einführung. Bern: Huber.
(2000). Adaption to Changing Health. Response Shift in quality-of-life research. Washington, DC: American Psychological Association.
(2001). Rumination as a common mechanism relating depressive risk factors to depression. Emotion, 1 (1), 25 – 37.
(2005). Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. The Neurologist, 11 (5), 257 – 270.
(1920). A constant error in psychological rating. Journal of Applied Psychology, 4, 25 – 29.
(2008). Anxiety undermines quality of life in ALS patients and caregivers. European Journal of Neurology, 15 (11), 1231 – 1236.
(2011). Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 303 (1 – 2). 114 – 118.
(1984). The epidemiology of depression: An update on sex differences in rates. Journal of Affective Disorders, 7 (3 – 4), 179 – 188.
(2006). Problems eliciting cues in SEIQoL-DW: Quality of life areas in small-cell lung cancer patients. Quality of Life Research, 15 (3), 441 – 449.
(2009). Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases, 4, 3.
(1992). Eine deutsche Form der „Reinforcement survey schedule” von Cautela und Kastenbaum. Paper presented at the 4. Kongress für Verhaltenstherapie, Münster.
(1997). Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Göttingen: Hogrefe.
(2010). Der Vergleich von ALS-Patienten und einer studentischen Stichprobe in den Variablen Depressivität, subjektive Lebensqualität und Wunsch nach einem beschleunigten Versterben. Unveröffentlichte Diplomarbeit, Julius-Maximilians Universität Würzburg.
(